0 477

Cited 129 times in

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

DC Field Value Language
dc.contributor.author박형천-
dc.date.accessioned2020-02-11T02:22:39Z-
dc.date.available2020-02-11T02:22:39Z-
dc.date.issued2019-
dc.identifier.issn0085-2538-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/174486-
dc.description.abstractIn November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative brought a diverse panel of experts in glomerular diseases together to discuss the 2012 KDIGO glomerulonephritis guideline in the context of new developments and insights that had occurred over the years since its publication. During this KDIGO Controversies Conference on Glomerular Diseases, the group examined data on disease pathogenesis, biomarkers, and treatments to identify areas of consensus and areas of controversy. This report summarizes the discussions on primary podocytopathies, lupus nephritis, anti-neutrophil cytoplasmic antibody-associated nephritis, complement-mediated kidney diseases, and monoclonal gammopathies of renal significance.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfKIDNEY INTERNATIONAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications-
dc.subject.MESHAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis-
dc.subject.MESHAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/genetics-
dc.subject.MESHBiomarkers/analysis-
dc.subject.MESHConsensus Development Conferences as Topic-
dc.subject.MESHDisease Progression-
dc.subject.MESHGenetic Testing-
dc.subject.MESHGlomerular Filtration Rate-
dc.subject.MESHGlomerulonephritis/etiology-
dc.subject.MESHGlomerulonephritis/pathology-
dc.subject.MESHGlomerulonephritis/therapy*-
dc.subject.MESHHumans-
dc.subject.MESHNephrology/methods-
dc.subject.MESHNephrology/standards-
dc.subject.MESHNephrosis, Lipoid/etiology-
dc.subject.MESHNephrosis, Lipoid/pathology-
dc.subject.MESHNephrosis, Lipoid/therapy*-
dc.subject.MESHParaproteinemias/complications-
dc.subject.MESHParaproteinemias/diagnosis-
dc.subject.MESHParaproteinemias/genetics-
dc.subject.MESHPodocytes/immunology-
dc.subject.MESHPodocytes/pathology-
dc.subject.MESHPractice Guidelines as Topic*-
dc.subject.MESHRisk Factors-
dc.subject.MESHTreatment Outcome-
dc.titleManagement and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorBrad H. Rovin-
dc.contributor.googleauthorDawn J. Caster-
dc.contributor.googleauthorDaniel C. Cattran-
dc.contributor.googleauthorKeisha L. Gibson-
dc.contributor.googleauthorJonathan J. Hogan-
dc.contributor.googleauthorMarcus J. Moeller-
dc.contributor.googleauthorDario Roccatello-
dc.contributor.googleauthorMichael Cheung-
dc.contributor.googleauthorDavid C. Wheeler-
dc.contributor.googleauthorWolfgang C. Winkelmayer-
dc.contributor.googleauthorJürgen Floege-
dc.contributor.googleauthorConference Participants-
dc.identifier.doi10.1016/j.kint.2018.11.008-
dc.contributor.localIdA01759-
dc.relation.journalcodeJ01941-
dc.identifier.eissn1523-1755-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0085253818308111-
dc.contributor.alternativeNamePark, Hyeong Cheon-
dc.contributor.affiliatedAuthor박형천-
dc.citation.volume95-
dc.citation.number2-
dc.citation.startPage281-
dc.citation.endPage295-
dc.identifier.bibliographicCitationKIDNEY INTERNATIONAL, Vol.95(2) : 281-295, 2019-
dc.identifier.rimsid64325-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.